Can Aspirin Lower Liver Cancer Risk in Cirrhosis?
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether taking low-dose aspirin can help prevent liver cancer in people with cirrhosis (scarring of the liver). Cirrhosis makes the liver more likely to develop cancer, and aspirin might reduce that risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with liver cirrhosis at least 6 months ago
- Liver function is stable (Child-Pugh score of 6 or lower, meaning your liver is still compensated or working reasonably well)
- You've had regular ultrasound or CT/MRI scans of your liver for at least 6 months before starting the trial
- No signs of liver cancer or suspicious growths detected in the past 6 months
- You are not currently taking aspirin, other blood thinners, or anti-inflammatory drugs like ibuprofen
- No history of bleeding problems, varices (enlarged veins in the esophagus), or peptic ulcers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the blood thinner apixaban can prevent liver cirrhosis from getting worse in people with alcohol-related liver disease. It may help reduce the risk of serious complications like fluid buildup or bleeding.
This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.
This early study tests whether the blood thinner pills rivaroxaban and apixaban can be used safely in people with liver cirrhosis that is not too severe. It may help doctors understand the safest way to prevent or treat blood clots in this group.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This trial tests whether atorvastatin (a cholesterol medicine) can lower the chance of liver cancer (HCC) in people with advanced liver scarring or cirrhosis. Participants are compared to placebo (inactive pill) while researchers track safety and cancer risk.
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.